Streetbeat News

Products Services

GPAK

Gamer Pakistan Inc. (NASDAQ:GPAK) has launched a new initiative to provide independent game developers with collaborative market research and in-depth audience testing in Pakistan. The initiative aims to provide developers with insights into gamer behavior, preferences, and engagement patterns, mass exposure, resource support, and market entry support. The company's CEO, Jim Knopf, highlighted the potential of the Pakistani market, with nearly 37 million gamers and 65% of the country's 207 million population under the age of 30.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:32 pm

QNRX

Quoin Pharmaceuticals has announced additional clinical data from an open-label, single-arm clinical trial in Netherton Syndrome. The data from six subjects shows well-defined efficacy signals across a number of study endpoints. No safety concerns have been observed in the study to date.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:30 pm

MBOT

Microbot Medical has received confirmation for the commencement of its CE Mark approval process during the first half of 2024. The company's designated Notified Body will conduct audits for ISO 13485 certification to ensure compliance with the QMS requirements of the EU MDR. The full CE Mark approval process for the LIBERTY® Robotic Surgical System will be carried out in parallel with the FDA regulatory process.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:22 pm

STLA

Stellantis N.V. (STLA) and Orano have signed a memorandum of understanding to establish a joint venture for recycling end-of-life electric vehicle batteries and scrap from gigafactories in Europe and North America. The partnership aims to support Stellantis' sustainable management of battery electric vehicle materials and its strategic plan to become a carbon net zero company by 2038. The joint venture will use Orano's innovative, low-carbon technology to recover all materials from lithium-ion batteries and manufacture new cathode materials. The venture is expected to start production in the first part of 2026.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:22 pm

CVM

CEL-SCI Corporation (NYSE:CVM) has released a video presentation detailing recent Phase 3 findings and its plans to seek immediate regulatory approvals for its immunotherapy drug Multikine. The drug has shown promising results in the treatment of newly diagnosed, advanced squamous cell carcinoma of the head and neck (SCCHN), with a 5-year survival rate of 73% compared to 45% for those who did not receive Multikine. The company is planning regulatory submissions based on these findings.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:21 pm

SYT

Siyata Mobile has partnered with Synch Communication to provide essential communication solutions for first responders in Israel. The partnership will see Synch's application integrated with Siyata's SD7 handsets.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:20 pm

EFTR

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) has initiated dosing in a Phase 1 trial evaluating tomivosertib in patients with Acute Myeloid Leukemia (AML). The trial will be conducted at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Tomivosertib is an inhibitor of mitogen-activator protein kinase interacting kinase (MNK) 1 and 2 and blocks phosphorylation of eukaryotic initiation factor 4E (eIF4E).

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:19 pm

LSTA

Lisata Therapeutics, Inc. (NASDAQ:LSTA) has announced the treatment of the first patient in the cholangiocarcinoma cohort of the BOLSTER Trial. The trial is a Phase 2a, double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 in patients with advanced solid tumors. The trial is expected to be completed in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:17 pm

SCYX

SCYNEXIS has presented new preclinical data on its second-generation antifungal, SCY-247, at the 11th Congress on Trends in Medical Mycology. The data, presented by Mahmoud Ghannoum, Ph.D, showed in vitro activity against a broad spectrum of fungal pathogens and dose-dependent tissue distribution in vivo.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:17 pm

BRAG

Bragg Gaming Group (BRAG) has announced an expansion of its content distribution network in Italy with Lottomatica Group S.p.A. (BIT: LTMC), Europe's leading online casino operator. The agreement will bring Bragg's Italian casino content portfolio to a large new Italian audience. Lottomatica is Italy's leading online casino operator with a 21% market share. Online casino revenues in Italy are estimated to grow 15% this year to $2.7 billion.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:16 pm